Drug Development Global Program

Prescription for a healthier world

PATH’s Drug Development program is working to develop and ensure availability and accessibility of safe and effective new medicines for diseases disproportionately affecting people in developing countries. By combining entrepreneurial energy, pharmaceutical expertise, and an innovative product development partnership model, we challenge the assumption that pharmaceutical research and development is too expensive to create the new medicines that the developing world desperately needs. Find out more »

A new era for malaria treatment

A new era for malaria treatment The first batches of antimalarial medicines produced with a new, non-seasonal source of artemisinin are on the way to reaching patients. Find out what this means for the millions of people affected by malaria each year. Read more»

Program spotlight

press release: First antimalarial treatments produced with semisynthetic artemisinin enter market »

fact sheet: Stabilizing the antimalarial drug supply »

infographic: Semisynthetic artemisinin »

on our blog: Shared goals to accelerate drug discovery »

Sign up for our e-newsletter

Our e-newsletter, A Healthy Dose, gives advocates, policymakers, government and agency leaders, and anyone interested in global health a quarterly update on our work. Each issue features reports from the field, news on the latest clinical trial milestones, and resources in nonprofit drug development. Sign up now »

Banner photo: Jonathan Torgovnik.

Comments are closed.